Europe Allergy Immunotherapies Market is expected to reach US$ 1,228.14 Mn by 2027

Sublingual Immunotherapy (SLIT) segment  by treatment is estimated to lead the market growth during the forecast period

According to The Insight Partners market research study of “Europe Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment, Allergy type and Distribution Channel,” The Europe allergy immunotherapies market was valued at US$ 544.14 million in 2019 and is projected to reach US$ 1,228.14 million by 2027; it is expected to grow at a CAGR of 10.8% during 2020–2027. The increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations are the key factors fueling the Europe allergy immunotherapies market growth.

Based on the treatment, the Europe allergy immunotherapies market is further segmented into the the SCIT segment held a larger share of the market in 2079. However, the SLIT segment is expected to grow at a higher CAGR during the forecast period. Allergen immunotherapy is a medical treatment useful for environmental allergies, insect bite allergies, and asthma. Positive results of various immunotherapies that are in clinical trials encourage the development activities of allergy immunotherapy-based drugs.  The market players are also adopting business expansion, collaboration, and new product development strategies to increase their market footprint.

The Europe allergy immunotherapy market is anticipated witness consistent growth in the coming years owing to increasing government expenditures on the healthcare sector for research and development in European countries. Additionally, high awareness regarding allergies and treatments available for the same, and increasing need for advanced treatments further pose lucrative growth opportunities to the market players.

Celsion Corporation, European and Developing Countries Clinical Trials Partnership (EDCTP), EuropaBio, European Federation of Biotechnology (EFB), and European Academy of Allergy and Clinical Immunology are among the leading companies operating in the Europe Allergy Immunotherapy market.     

Europe Allergy Immunotherapies Market , By Country, 2019 & 2027 (% share)

---

Europe Allergy Immunotherapies Market to Grow at a CAGR of 10.8% to reach US$ 1,228.14 Million from 2020 to 2027

Download Free Sample

---

Europe Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)); Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy and Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), and Country

The report segments Europe Allergy Immunotherapies Market as follows:

Market Segmentation

By Treatment

• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)

By Allergy Type

• Allergic Rhinitis
• Asthma
• Food Allergy
• Venom Allergy
• Others
•  

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy

By Country

• Germany
• Spain
• Italy
• France
• UK